ID

13213

Descripción

Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00169039

Link

https://clinicaltrials.gov/show/NCT00169039

Palabras clave

  1. 24/1/16 24/1/16 -
Subido en

24 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT00169039

Eligibility Schizophrenia NCT00169039

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
19-60 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of schizophrenia
Descripción

schizophrenia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0036341
bprs score > 50
Descripción

bprs score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029941
clinical global impressions rating > 4
Descripción

clinical global impression

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3639708
one of the following: bprs items rated greater than or equal to 4, conceptual disorganization, suspiciousness, hallucinations, unusual thought content.
Descripción

bprs items, conceptual disorganization, suspiciousness, hallucinations, unusual thought content

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029941
at least 2 six-week trials of different neuroleptics given at a dosage equivalent to at least 600 mg per day of chlorpromazine or at least 1 eight-week trial of a neuroleptic given at a dosage equivalent to at least 800 mg per day of chlorpromazine.
Descripción

neuroleptics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2]
C0008286
the patient (or the patient's authorized legal representative) must understand the nature of the study and sign the informed consent.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of substance dependence within the past 2 months
Descripción

substance dependence

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
major medical problems precluding the use of clozapine
Descripción

contraindications clozapine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0009079
pregnancy or lactation
Descripción

pregnancy or lactation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
a serious suicide/homicide risk
Descripción

suicidal, homicide risk

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0438696
UMLS CUI [2]
C0019872

Similar models

Eligibility Schizophrenia NCT00169039

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
19-60 years of age
boolean
C0001779 (UMLS CUI [1])
schizophrenia
Item
diagnosis of schizophrenia
boolean
C0036341 (UMLS CUI [1])
bprs score
Item
bprs score > 50
boolean
C0029941 (UMLS CUI [1])
clinical global impression
Item
clinical global impressions rating > 4
boolean
C3639708 (UMLS CUI [1])
bprs items, conceptual disorganization, suspiciousness, hallucinations, unusual thought content
Item
one of the following: bprs items rated greater than or equal to 4, conceptual disorganization, suspiciousness, hallucinations, unusual thought content.
boolean
C0029941 (UMLS CUI [1])
neuroleptics
Item
at least 2 six-week trials of different neuroleptics given at a dosage equivalent to at least 600 mg per day of chlorpromazine or at least 1 eight-week trial of a neuroleptic given at a dosage equivalent to at least 800 mg per day of chlorpromazine.
boolean
C0040615 (UMLS CUI [1])
C0008286 (UMLS CUI [2])
informed consent
Item
the patient (or the patient's authorized legal representative) must understand the nature of the study and sign the informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
substance dependence
Item
history of substance dependence within the past 2 months
boolean
C0038586 (UMLS CUI [1])
contraindications clozapine
Item
major medical problems precluding the use of clozapine
boolean
C0009488 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0009079 (UMLS CUI [2,2])
pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
suicidal, homicide risk
Item
a serious suicide/homicide risk
boolean
C0438696 (UMLS CUI [1])
C0019872 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial